• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aeterna Zentaris Inc

+ Add to Watchlist

AEZS:US

1.1700 USD 0.0200 1.74%

As of 20:10:00 ET on 10/24/2014.

Snapshot for Aeterna Zentaris Inc (AEZS)

Open: 1.1800 Day's Range: 1.1200 - 1.1800 Volume: 1,232,168
Previous Close: 1.1500 52wk Range: 0.8200 - 1.7400 1-Yr Rtn: -17.02%

Stock Chart for AEZS

No chart data available.
  • AEZS:US 1.1700
  • 1D
  • 1M
  • 1Y
1.1500
Interactive AEZS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEZS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.5900
Est. PEG Ratio -
Market Cap (M USD) 68.79
Shares Outstanding (M) 58.79
30 Day Average Volume 1,135,387
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEZS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AEZS

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval.

David A DoddPresident/CEODennis TurpinSenior VP/CFO
Philip A TheodoreSenior VP/CAO/Secy/Gen CnslJude DingesSenior VP/Chief Commercial Ofcr
More Company Profile & Key Executives for AEZS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil